Antonetti Capital Management’s Gilead Sciences GILD Stock Holding History

Antonetti Capital Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$189K	Buy	2,521 +160	+7%	+$12.3K	0.3%	46
2023 Q2	$182K	Sell	2,361 -172	-7%	-$13.7K	0.26%	44
2023 Q1	$210K	Sell	2,533 -1,400	-36%	-$116K	0.31%	42
2022 Q4	$338K	Sell	3,933 -1,055	-21%	-$83.5K	0.46%	35
2022 Q3	$308K	Hold	4,988	–	–	0.35%	36
2022 Q2	$308K	Hold	4,988	–	–	0.32%	38
2022 Q1	$297K	Hold	4,988	–	–	0.28%	44
2021 Q4	$362K	Hold	4,988	–	–	0.28%	56
2021 Q3	$348K	Buy	+4,988	New	+$350K	0.28%	51
2014 Q3	–	Sell	-150	Closed	-$12K	–	151
2014 Q2	$12K	Buy	+150	New	+$11.7K	0.01%	148

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Antonetti Capital Management's GILD Position: Q3 2023 in Review

Antonetti Capital Management increased its Gilead Sciences (GILD) stake by 6.8% in Q3 2023, buying an estimated $12.3K and bringing the position to 2,521 shares worth $189K. The position accounts for 0.3% of the portfolio, ranked #46.

Antonetti Capital Management first reported a position in GILD in Q2 2014 and has held it in 10 quarters since. The position peaked at $362K in Q4 2021. 1,681 funds tracked by Wall St. Rank hold GILD as of Q3 2023.

Antonetti Capital Management held 2,521 shares of Gilead Sciences worth $189K as of Q3 2023.
Antonetti Capital Management bought 160 Gilead Sciences shares in Q3 2023, an estimated $12.3K.
Gilead Sciences made up 0.3% of Antonetti Capital Management's portfolio in Q3 2023, its #46 holding.
Antonetti Capital Management first reported a position in Gilead Sciences in Q2 2014 and has held it in 10 quarters since.
Antonetti Capital Management's Gilead Sciences position peaked at $362K in Q4 2021.
1,681 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2023.

Based on Antonetti Capital Management's 13F filing for Q3 2023, filed 9 Nov 2023.